Paydirt
KYTX
Ticker

Kyverna Therapeutics, Inc.

KYTX

KYTX has 3 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 2 purchases and 1 sale. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Dec 18 2025 and filed Dec 22 2025. The most active filer was Beth C Seidenberg with 1 filing.

Add to watchlist
Filings, ttm
3
2 buys · 1 sell
Traders, ttm
3
3 insiders
Volume, ttmiDollar value disclosed in the window
$2.3M
estimated for Congress, as filed for insiders
Median delay
4d
execution to disclosure
Last traded
Dec 18 2025
Filed Dec 22 2025
ADViAverage daily dollar volume
–
not on file
Share price · 12M
$7.77 (+19.2%)
$11.25$8.33$5.41Sep 22 2025Feb 27Aug 5

Adjusted for splits and dividends.

Volume by month
$2.0M$1000K$0Oct 2024Apr 2025Oct 2025Apr 2026Dec 2025 · buys $2.0MDec 2025 · sells $293K
Buys $2.0M Sells $293K

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
BS Beth C Seidenberg Director 1 filing KW Karen Marie Walker Chief Technology Officer 1 filing WP Westlake BioPartners Opportunity Fund I, L.P. 10% owner 1 filing
Recent filings
Beth C SeidenbergPURCHASE Director $1000K
133,333 sh × $7.50
Exec Dec 18 2025
Filed Dec 22 2025 · 11:43 AM ET Westlake BioPartners Opportunity Fund I, L.P.PURCHASE 10% owner $1000K
133,333 sh × $7.50
Exec Dec 18 2025
Filed Dec 22 2025 · 11:42 AM ET Karen Marie WalkerSALE Chief Technology Officer $293K
23,998 sh × $12.20
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET